<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03388593</url>
  </required_header>
  <id_info>
    <org_study_id>ZS-01-306</org_study_id>
    <nct_id>NCT03388593</nct_id>
  </id_info>
  <brief_title>Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.</brief_title>
  <official_title>A Multi-center, Randomized, Double-blined, Placebo Parallel Controlled Phase III Clinical Trial to Evaluate the Effect of Injectable Neucardin on the Mortality of Subjects With Chronic Systolic Heart Failure on Standard HF Therapy.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zensun Sci. &amp; Tech. Co., Ltd.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zensun Sci. &amp; Tech. Co., Ltd.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate efficacy of rhNRG-1 in reducing the death rate of
      heart failure subjects with baseline NT-proBNP level between 600 pg/ml and 1700 pg/mL and
      NYHA class II to III.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The mortality of chronic heart failure patients remains high, in spite of current treatment.
      RhNRG-1(recombinant human neuregulin-1)directly work on the cardiomyocyte and restored the
      normal structure and function of it. Both the preclinical trials, phase II clinical trials
      and already completed phase III clinical trails have confirmed that rhNRG-1 effectively
      enhance the heart function, reverse the remodeling of left ventricular, and reduce all-cause
      mortality in heart failure animals and humans. More importantly, rhNRG-1 can significantly
      reduce the mortality of heart failure subjects with baseline NT-proBNP level ≤1600 fmol/mL
      and NYHA class II to III. In this phase III study, the investigators will further confirm the
      efficacy of rhNRG-1 in reducing the death rate of heart failure subjects with baseline
      NT-proBNP level between 600 pg/ml and 1700 pg/mL and NYHA class II to III.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 23, 2018</start_date>
  <completion_date type="Anticipated">February 2023</completion_date>
  <primary_completion_date type="Anticipated">February 2022</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause mortality</measure>
    <time_frame>1 year</time_frame>
    <description>Including deaths from cardiovascular and non-cardiovascular causes, Log-Rank test was used for comparison between groups, and Kaplan-Meier survival curves were plotted; COX proportional hazard model was used to estimate the HR and its 95% confidence interval.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mortality caused by cardiovascular events</measure>
    <time_frame>1 year</time_frame>
    <description>Log-Rank test was used for comparison between groups, and Kaplan-Meier survival curves were plotted; COX proportional hazard model was used to estimate the HR and its 95% confidence interval.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality of female subjects</measure>
    <time_frame>1 year</time_frame>
    <description>Log-Rank test was used for comparison between groups, and Kaplan-Meier survival curves were plotted; COX proportional hazard model was used to estimate the HR and its 95% confidence interval.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause mortality of male subjects</measure>
    <time_frame>1 year</time_frame>
    <description>Log-Rank test was used for comparison between groups, and Kaplan-Meier survival curves were plotted; COX proportional hazard model was used to estimate the HR and its 95% confidence interval.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of all-cause re-hospitalization</measure>
    <time_frame>1 year</time_frame>
    <description>The Kaplan-Meier curve was used to describe the cumulative incidence rate of the first re-hospitalization, and the differences between the two groups were compared using Log-Rank.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percentage of Participants with re-hospitalization caused by worsening heart failure</measure>
    <time_frame>1 year</time_frame>
    <description>The Kaplan-Meier curve was used to describe the cumulative incidence rate of the first re-hospitalization, and the differences between the two groups were compared using Log-Rank.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change of NT-proBNP level at the 25th week and 52th week</measure>
    <time_frame>1 year</time_frame>
    <description>The paired t test or signed rank sum test was used to compare the changes before and after treatment in each group, and the comparison between groups was performed by analysis of variance or Wilcoxon rank sum test.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>New York Heart Association (NYHA) functional classification</measure>
    <time_frame>1 year</time_frame>
    <description>For the NYHA cardiac functional grading after administration, summarize the number and percentage of subjects by different study visit period, compare the efficacy differences among test groups and control groups. In addition, calculate the changes of NYHA cardiac functional grade from baseline of the subjects. The intragroup changes will be analyzed by signed-rank sum test, intergroup comparison will be conducted by Wilcoxon test.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1600</enrollment>
  <condition>Chronic Heart Failure</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo in addition to standard therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>rhNRG-1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>rhNRG-1 in addition to standard therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>rhNRG-1</intervention_name>
    <description>10 hours per day i.v drip for the first 10 days (0.6ug/kg/day), followed by weekly 10 minutes i.v bolus (0.8ug/kg/day), from the 3rd week for 23 weeks</description>
    <arm_group_label>rhNRG-1</arm_group_label>
    <other_name>Neucardin™</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>10 hours per day i.v drip for the first 10 days (0ug/kg/day), followed by weekly 10 minutes i.v bolus (0ug/kg/day), from the 3rd week for 23 weeks</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1. Age between 18 and 75, gender balance (no more than 960 subjects of either gender
             in total 1600 subjects).

          -  2. Left ventricular ejection fraction (LVEF)≤40% (ECHO).

          -  3. Subjects with chronic heart failure (NYHA class II OR III ).

          -  4. 600 pg/ml ≤NT-proBNP≤1700 pg/ml ( by Roche assay Kit in central lab).

          -  5. Diagnosed as chronic systolic heart failure (history, symptoms, signs), and in
             stable condition in the last one month.

          -  6. Receiving standard therapy for chronic heart failure, reach target dose or max
             tolerable dose for one month, or has not changed the dose for one month before
             randomization.

          -  7. Capable of signing the informed consent form.

        Exclusion Criteria:

          -  1. New chronic heart failure patients, or patients receiving standard therapy on
             chronic heart failure for less than 3 months.

          -  2. NYHA functional class I OR IV.

          -  3. NT-proBNP &lt; 600 pg/ml OR NT-proBNP＞1700 pg/ml (by Roche assay Kit in central lab).

          -  4. Patients with hypertrophic cardiomyopathy, rheumatic heart disease, constrictive
             pericarditis, significant valvular pathological change or congenital heart diseases,
             primary or secondary severe pulmonary artery hypertension.

          -  5. Ischemic heart failure without recanalization or with recanalization in recent six
             months.

          -  6. Acute MI in the last 3 months.

          -  7. Unstable angina.

          -  8. Patients with acute pulmonary edema or acute hemodynamic disorder.

          -  9. Chronic heart failure patients with acute hemodynamic disorder or acute
             decompensation in the last 1 month (symptoms and signs suggest worsening chronic heart
             failure and may require intravenous drug therapy).

          -  10. Patients with right heart failure caused by pulmonary disease.

          -  11. Patients diagnosed with pericardial effusion (&gt;50 ml) or pleural effusion(&gt;200
             ml), or evidenced by Echocardiogram.

          -  12. Cardiac surgery or cerebrovascular accident within recent six months.

          -  13. Preparing for heart transplantation or CRT, or has received CRT.

          -  14. Serious ventricular arrhythmia (sustained ventricular tachycardia or frequent
             paroxysmal ventricular tachycardia).

          -  15.Diagnosis of perinatal or chemotherapy-induced cardiomyopathy in last 12 months.

          -  16. Serious hepatic or renal dysfunction (bilirubin 1.5 times above the normal upper
             limit, AST or ALT 2 times above the normal upper limit, serum creatinine＞2.0mg/dL, HBV
             or HCV positive).

          -  17. Serum potassium &lt;3.2 mmol/L or &gt;5.5 mmol/L.

          -  18. Systolic blood pressure &lt;90mmHg or &gt;160mmHg.

          -  19. Women of childbearing age who have a pregnancy plan within 2 years (women of
             childbearing age are defined as women who have a pregnancy physiology).

          -  20. Pregnant or lactating women.

          -  21. Patients who participated in any clinical trial in the recent three months.

          -  22. Subject with a life expectancy less than 6 months as assessed by the investigator.

          -  23. Serious nervous system diseases (Alzheimer's disease, advanced Parkinsonism),lower
             limb defects, or deaf-mute.

          -  24. History of any malignancy or suffering from cancer, or biopsy proven pre-malignant
             condition (e.g., DICS or cervical atypia).

          -  25. Evidence (physical examination, chest X-ray (CXR), ECHO or other tests) shows some
             active malignancy or adenoidal hypertrophy or neoplasm that has an effect on heart
             function or the endocrine system, e.g., pheochromocytoma or hyperthyroidism (Thyroid
             nodules with normal thyroid function do not need to be excluded).

          -  26. As judged by the investigator that the subject cannot complete the study or adhere
             to the study requirements (due to the management reasons or others).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Runlin Gao, Ph.D,MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fuwai Hospital and Cardiovascular Institute, Chinese Academy of Medical Sciences</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Xiaorui Wang, Ph.D</last_name>
    <phone>86-21-50802627</phone>
    <phone_ext>196</phone_ext>
    <email>wangxiaorui@zensun.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Runlin Gao, Ph.D,MD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing Hospital of Traditional Chinese Medicine</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100010</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongxu Liu</last_name>
    </contact>
    <investigator>
      <last_name>Hongxu Liu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Navy General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100048</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tianchang Li</last_name>
    </contact>
    <investigator>
      <last_name>Tianchang Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Beijing Jingmei Group General Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianping Luo</last_name>
    </contact>
    <investigator>
      <last_name>Jianping Luo</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fuwai Hospital and Cardiovascular Institute, Chinese Academy of Medical Sciences</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jian Zhang, MD, Ph.D</last_name>
      <phone>86-10-88398772</phone>
    </contact>
    <investigator>
      <last_name>Jian Zhang, MD, Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Chongqing Three Gorges Medical College</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>404000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gang Xiong</last_name>
    </contact>
    <investigator>
      <last_name>Gang Xiong</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chongqing Emergency Medical Center</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ying Zhang</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chongqing Three Gorges Central Hospital</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaohua Pang</last_name>
    </contact>
    <investigator>
      <last_name>Xiaohua Pang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sun Yai-sen Memorial hospital Sun Yai-sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510120</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jingfeng Wang</last_name>
    </contact>
    <investigator>
      <last_name>Jingfeng Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guangdong Second Provincial Central Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510317</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yuhui Li</last_name>
    </contact>
    <investigator>
      <last_name>Yuhui Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Guangzhou Panyu Central Hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>511400</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guoqin Chen</last_name>
    </contact>
    <investigator>
      <last_name>Guoqin Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Guangdong Medical University</name>
      <address>
        <city>Zhanjiang</city>
        <state>Guangdong</state>
        <zip>524001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jianying Chen</last_name>
    </contact>
    <investigator>
      <last_name>Jianying Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Fifth Affiliated Hospital Sun Yat-Sen University</name>
      <address>
        <city>Zhuhai</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiufang Lin</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Zunyi</name>
      <address>
        <city>Zunyi</city>
        <state>Guizhou</state>
        <zip>133012</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qianfeng Jiang</last_name>
    </contact>
    <investigator>
      <last_name>Qianfeng Jiang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Haikou People's Hospital</name>
      <address>
        <city>Haikou</city>
        <state>Hainan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shijuan Lu</last_name>
    </contact>
    <investigator>
      <last_name>Shijuan Lu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third People's Hospital of Hainan Province</name>
      <address>
        <city>Sanya</city>
        <state>Hainan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ling Lin</last_name>
    </contact>
    <investigator>
      <last_name>Ling Lin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>HanDan Central Hospital</name>
      <address>
        <city>Handan</city>
        <state>Hebei</state>
        <zip>056001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongsen Tian</last_name>
    </contact>
    <investigator>
      <last_name>Hongsen Tian</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>First Hospital of Handan</name>
      <address>
        <city>Handan</city>
        <state>Hebei</state>
        <zip>056002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiufeng Zhao</last_name>
    </contact>
    <investigator>
      <last_name>Xiufeng Zhao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>980 Hospital of PLA Joint Logistics Support Force (Bethune International Peace Hospital)</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <zip>05000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ru Leisheng</last_name>
    </contact>
    <investigator>
      <last_name>Ru Leisheng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Xingtai Medical College</name>
      <address>
        <city>Xingtai</city>
        <state>Hebei</state>
        <zip>054000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dongmei Gao</last_name>
    </contact>
    <investigator>
      <last_name>Dongmei Gao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xingtai People's Hospital</name>
      <address>
        <city>Xingtai</city>
        <state>Hebei</state>
        <zip>054000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qingmin Wei</last_name>
    </contact>
    <investigator>
      <last_name>Qingmin Wei</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third Affiliated Hospital of Qiqihar Medical University</name>
      <address>
        <city>Qiqihar</city>
        <state>Heilongjiang</state>
        <zip>161002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Haifeng Shao</last_name>
    </contact>
    <investigator>
      <last_name>Haifeng Shao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Huaihe Hospital of Henan University</name>
      <address>
        <city>Kaifeng</city>
        <state>Henan</state>
        <zip>475000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruili He</last_name>
    </contact>
    <investigator>
      <last_name>Ruili He</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Luoyang</name>
      <address>
        <city>Luoyang</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qunsheng Zhang</last_name>
    </contact>
    <investigator>
      <last_name>Qunsheng Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Puyang Oilfield General Hospital</name>
      <address>
        <city>Puyang</city>
        <state>Henan</state>
        <zip>457001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fuxian Ren</last_name>
    </contact>
    <investigator>
      <last_name>Fuxian Ren</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yu Zhao</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First People's Hospital of Xinxiang</name>
      <address>
        <city>Xinxiang</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guiye Zhao</last_name>
    </contact>
    <investigator>
      <last_name>Guiye Zhao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Pepole's hospital of Xinzheng</name>
      <address>
        <city>Xinzheng</city>
        <state>Henan</state>
        <zip>451150</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yanhong Li</last_name>
    </contact>
    <investigator>
      <last_name>Yanhong Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zhengzhou First People's Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>450004</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hongwei Yu</last_name>
    </contact>
    <investigator>
      <last_name>Hongwei Yu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Luoyang center hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <zip>471099</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shouyan Zhang</last_name>
    </contact>
    <investigator>
      <last_name>Shouyan Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Henan Provincial Chest Hospital</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juan Chen</last_name>
    </contact>
    <investigator>
      <last_name>Juan Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Xiangya Hospital Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410008</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zaixin Yu</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Hunan Provincial People's Hospital</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianqiang Peng</last_name>
    </contact>
    <investigator>
      <last_name>Jianqiang Peng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second Hospital. University of South China</name>
      <address>
        <city>Hengyang</city>
        <state>Hunan</state>
        <zip>421001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaofeng Zeng</last_name>
    </contact>
    <investigator>
      <last_name>Gaofeng Zeng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Baotou Medical College of Inner Mongolia University of Science &amp; Technology</name>
      <address>
        <city>Baotou</city>
        <state>Inner Mongolia</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xuefeng Lin</last_name>
    </contact>
    <investigator>
      <last_name>Xuefeng Lin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chifeng Municipal Hospital</name>
      <address>
        <city>Chifeng</city>
        <state>Inner Mongolia</state>
        <zip>024000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiandong Sun</last_name>
    </contact>
    <investigator>
      <last_name>Xiandong Sun</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospital of Xuzhou Medical College</name>
      <address>
        <city>Xuzhou</city>
        <state>Jiangsu</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yong Xia</last_name>
    </contact>
    <investigator>
      <last_name>Yong Xia, MD,Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jiujiang Hospital Affiliated to Nanchang University</name>
      <address>
        <city>Jiujiang</city>
        <state>Jiangxi</state>
        <zip>332000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xihu Yin</last_name>
    </contact>
    <investigator>
      <last_name>Xihu Yin</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jilin Academy of Traditional Chinese Medicine</name>
      <address>
        <city>Chang Chun</city>
        <state>Jilin</state>
        <zip>130021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shurong Liu</last_name>
    </contact>
    <investigator>
      <last_name>Shurong Liu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Affiliated Hospital of Changchun University of Chinese Medicine</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yue Deng</last_name>
    </contact>
    <investigator>
      <last_name>Yue Deng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jilin University Sino-Japanese Friendship Hospital</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fanbo Meng</last_name>
    </contact>
    <investigator>
      <last_name>Fanbo Meng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yushi Wang</last_name>
    </contact>
    <investigator>
      <last_name>Yushi Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Meihekou Central Hospital</name>
      <address>
        <city>Meihekou</city>
        <state>Jilin</state>
        <zip>135000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jinliang Zhang</last_name>
    </contact>
    <investigator>
      <last_name>Jinliang Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Siping Central People's Hospital</name>
      <address>
        <city>Siping</city>
        <state>Jilin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhihua Fang</last_name>
    </contact>
    <investigator>
      <last_name>Zhihua Fang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tonghua Central Hospital</name>
      <address>
        <city>Tonghua</city>
        <state>Jilin</state>
        <zip>134000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xuxia Zhang</last_name>
    </contact>
    <investigator>
      <last_name>Xuxia Zhang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The People's Hospital of Liaoning Province</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110016</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhanquan Li</last_name>
    </contact>
    <investigator>
      <last_name>Zhanquan Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shengjing Hospital Affiliated to China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shumei Ma</last_name>
    </contact>
    <investigator>
      <last_name>Shumei Ma</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Affiliated Hospital of Shaanxi University of Chinese Medicine</name>
      <address>
        <city>Xianyang</city>
        <state>Shaanxi</state>
        <zip>712000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ling Chen</last_name>
    </contact>
    <investigator>
      <last_name>Ling Chen</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Jinan Central Hospital</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <zip>250013</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Miao</last_name>
    </contact>
    <investigator>
      <last_name>Wei Miao</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Qilu Hospital of Shandong University</name>
      <address>
        <city>Jinan</city>
        <state>Shandong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ming Zhong, MD,Ph.D</last_name>
    </contact>
    <investigator>
      <last_name>Ming Zhong, MD,Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Central hospital of minhang District</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wei Hu</last_name>
    </contact>
    <investigator>
      <last_name>Wei Hu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Sixth People's Hospital, Shanghai Jiaotong University</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>shanghai</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jingwei Pan</last_name>
    </contact>
    <investigator>
      <last_name>Jingwei Pan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Oriental hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huimin Fan</last_name>
    </contact>
    <investigator>
      <last_name>Huimin Fan</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanghai Yangpu District Central Hospital</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jiahong Wang</last_name>
    </contact>
    <investigator>
      <last_name>Jiahong Wang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Central Hospital of Putuo District, Shanghai</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zongjun Liu, MD,Ph.D</last_name>
    </contact>
    <investigator>
      <last_name>Zongjun Liu, MD,Ph.D</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Second Hospital of Shanxi Medical University</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <zip>030001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Zhiming Yang</last_name>
    </contact>
    <investigator>
      <last_name>Zhiming Yang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shanxi cardiovascular disease hospital</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <zip>030024</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Huiyuan Han</last_name>
    </contact>
    <investigator>
      <last_name>Huiyuan Han</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Taiyuan City Central Hospital</name>
      <address>
        <city>Taiyuan</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Suspended</status>
  </location>
  <location>
    <facility>
      <name>Pepole's hospital of DeYang city</name>
      <address>
        <city>Deyang</city>
        <state>Sichuan</state>
        <zip>618000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaojian Deng</last_name>
    </contact>
    <investigator>
      <last_name>Xiaojian Deng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Second People's Hospital of Neijiang</name>
      <address>
        <city>Neijiang</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Quanwei Liu</last_name>
    </contact>
    <investigator>
      <last_name>Quanwei Liu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Wuqing pepole's hospital</name>
      <address>
        <city>Tianjing</city>
        <state>Tianjing</state>
        <zip>300000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Feng Ling</last_name>
    </contact>
    <investigator>
      <last_name>Feng Ling</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fourth Affiliated Hospital of Xinjiang Medical University</name>
      <address>
        <city>Xinjiang</city>
        <state>Xinjiang</state>
        <zip>830054</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Peng Li</last_name>
    </contact>
    <investigator>
      <last_name>Peng Li</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Third People's Hospital of Yunnan Province</name>
      <address>
        <city>Kunming</city>
        <state>Yunnan</state>
        <zip>650011</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yunfei Hong</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Kunming Medical College</name>
      <address>
        <city>Kunming</city>
        <state>Yunnan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenwei Bai</last_name>
    </contact>
    <investigator>
      <last_name>Wenwei Bai</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shulan (Hangzhou) Hospital</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liping Ma</last_name>
    </contact>
    <investigator>
      <last_name>Liping Ma</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Taizhou Hospital of Zhejiang Province</name>
      <address>
        <city>Linhai</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianjun Jiang</last_name>
    </contact>
    <investigator>
      <last_name>Jianjun Jiang</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Quzhou people's hospital</name>
      <address>
        <city>Quzhou</city>
        <state>Zhejiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xiaoming Tu</last_name>
    </contact>
    <investigator>
      <last_name>Xiaoming Tu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>December 19, 2017</study_first_submitted>
  <study_first_submitted_qc>December 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">January 3, 2018</study_first_posted>
  <last_update_submitted>January 14, 2020</last_update_submitted>
  <last_update_submitted_qc>January 14, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic heart failure</keyword>
  <keyword>neuregulin</keyword>
  <keyword>mortality</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

